MHRA Approves UK's First Nasal Spray for Anaphylaxis
This marks the first time a needle-free formulation is available in the UK for this use.
The spray, called EURneffy, is manufactured by ALK-Abelló A/S, a pharmaceutical company based in Denmark. It was authorised for use in the European Union in August 2023.
UK approval followed the MHRA's International Recognition Procedure, introduced in January 2024. The pathway enables the MHRA to align with decisions made by trusted global regulatory partners.
Alternative to Adrenaline Auto-Injectors
Adrenaline is the standard emergency treatment for anaphylaxis and is usually administered by auto-injectors pens. EURneffy is the first approved nasal spray alternative.
The ready-to-use spray is suitable for adults and children weighing 30 kg (about 66 lbs) or more. It delivers its entire contents of 2 mg of adrenaline with a single activation, even when the user has nasal congestion. It is indicated for the emergency treatment of allergic reactions caused by insect stings or bites, foods, medicinal products, and other allergens. It can also be used to treat idiopathic or exercise-induced anaphylaxis.
According to ALK-Abelló, the product offers a 30-month shelf life and better temperature stability compared with traditional adrenaline auto-injectors.
Patients Should Always Carry Two Doses
Patients are advised to carry two doses of adrenaline in case a second dose is needed. A second dose should be given in the same nostril after 10 minutes if symptoms persist or recur.
Patients should also inform friends or family about their condition in case help is needed during a reaction.
Biphasic anaphylaxis — a delayed recurrence of symptoms — remains a risk. Patients should seek immediate medical attention after any severe allergic reaction, regardless of whether symptoms resolve.
The MHRA cautioned that the spray's plunger must not be pressed before insertion into the nostril, as this will release the single dose prematurely.
Efficacy and Tolerability Supported by Trial Data
Presentations at the European Academy of Allergy and Clinical Immunology congress last month in Glasgow highlighted that Eurneffy nasal adrenaline spray addressed "unmet needs and current challenges in the emergency management of anaphylaxis".
Ethical and practical constraints prevent trials in patients experiencing acute anaphylaxis. However, data from ALK-Abelló's development programme, involving more than 700 participants, demonstrated that the spray produced a pharmacological response comparable with that of intramuscular adrenaline auto-injectors.
Real-world data also supported the effectiveness of the nasal adrenaline spray in acute situations.
No serious adverse events were reported in clinical studies. The most frequently occurring adverse reactions were reported only after a second 2 mg dose (4 mg total). These included throat irritation (18.8%), headache (17.6%), nasal discomfort (12.9%), and feeling jittery (10.6%).
Ongoing Safety Monitoring
The MHRA will continue to monitor the safety and effectiveness of Eurneffy.
Healthcare professionals and patients are urged to report suspected side effects through the Yellow Card scheme.
Further information, including the Patient Information Leaflet and Summary of Product Characteristics, will be available on the MHRA website within seven days of approval.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
Sir Roger Daltrey is afraid he won't make it to the end of The Who tour
Sir Roger Daltrey fears he won't make it to the end of The Who tour because he fears he has "the potential to get really ill".
Yahoo
an hour ago
- Yahoo
Care worker who left suicidal teenager alone had fake ID and fled UK after she died, inquest told
An agency care worker who failed to supervise a suicidal teenage girl at a scandal-hit mental health hospital was working under a fake ID and fled the country shortly after she died, an inquest has been told. Ruth Szymankiewiczat, 14, died after she was left alone at Huntercombe Hospital, near Maidenhead in Berkshire, despite requiring constant one-to-one observation, jurors at the inquest were told. The hearing was told the support worker who had been responsible for monitoring Ruth had only gone through a day or day-and-a-half of online training before his first shift at the children's psychiatric hospital on February 12, 2022. He left his shift at 8pm when it ended, but should have waited to hand over to another worker before doing so, to ensure Ruth could be watched at all times. But the coroner told the jury he 'just left', meaning Ruth was left alone for 15 minutes. In that time, Ruth, who had an eating disorder, made her way to her room where she committed an act of self harm. She was found and resuscited and transferred to the local acute hospital, John Radcliffe in Oxford, where she was admitted into intensive care. Ruth died two days later, on 14 February 2022, having suffered brain injury. Assitant coroner for Buckinghamshire, Ian Wade, said it later emerged that the worker, who joined the hospital on the day Ruth was left unattended, had been using false identity documents and was hired through an agency under a false name, Ebo Achempong. 'The evidence showed he had been employed through an agency, who checked his identity documents, and they even trained him by putting him through a day or day-and-a-half course,' Mr Wade told jurors. 'It appears that these particular processes were the norm and were sufficient to enable a hospital to employ this person. But on February 12, he did not keep Ruth under a constant watch. 'Some time around 8pm in the evening, this man ended his shift without knowing where she was and without making sure that he handed her over to another member of staff to continue the one-to-one care regime. 'He simply left.' Mr Wade continued: 'It turned out he wasn't Ebo Achempong, that was a false name. He had been assisted to acquire a false identity documents and he never returned to work at Huntercombe.' After Ruth's death, police tracked down the worker's phone which revealed he had gone 'to Heathrow airport and got on a plane to Ghana'. The coroner said police think they know 'who he truly was' but that he was "never seen again" after leaving the country. 'It seems that he learned what happened that evening,' Mr Wade said. "He let Ruth down. He let everyone down.' The inquest, which started on Monday, heard Ruth should have been under continuous one to one observations and watched at all times following a suicide attempt on 7 February. When Ms Szymankiewicz was left unsupervised, she was able to asphyxiate herself, the coroner said. A post-mortem examination carried out by the Home Office later determined the preliminary cause of death to be 'hypoxic ischemic encephalopathy' – a type of brain damage due to lack of oxygen. After Ruth's death, the Care Quality Commission launched a criminal investigation alongside the police. Police have taken no further action. The CQC have not stated whether they will take not yet taken forward a prosecution. The court further heard privately-run Huntercombe Hospital had been inspected twice by the Care Quality Commission (CQC) prior to the incident. 'The CQC had not reported favourably on Huntercombe,' the coroner told the inquest. The Huntercombe Hospital in Maidenhead, also called Taplow Manor, closed last year after joint investigations by The Independent and Sky News. It was part of a group, formerly run by The Huntercombe Group and now taken over by Active Care Group. Ruth's parents described the teenager as having 'lived life whole heartedly'. The inquest at Buckinghamshire Coroner's Court in Beaconsfield continues.
Yahoo
an hour ago
- Yahoo
Bird flu case confirmed at farm in Norfolk
The first case of bird flu since restrictions were lifted in Norfolk has been detected in Norfolk. Defra has confirmed that a case of highly pathogenic H5N1 strain of avian influenza was found at a farm near Attleborough yesterday. A 3km protection zone and a 10km surveillance zone have been put in place by the government agency. Defra also confirmed that "all poultry on the premises will be humanely culled". A protection zone has been put in place near Attleborough (Image: Defra) It comes after restrictions were lifted for the county on May 15. The previous outbreak sparked the enforcement of a mandatory housing order across the county, forcing birds to be kept indoors to stop the disease from spreading. Earlier in the year, cases had been detected in Loddon, King's Lynn and Wymondham. READ MORE: The outbreak came simultaneously with the virus being detected in 15 dead seals at Blakeney Point, one of England's best-known colonies. However, according to Defra's scientific risk assessment the threat had fallen, meaning poultry and other captive birds returned to being kept outside again.
